Observational studyBMC psychiatry2025
Bipolar disorder at mixed states and major depressive disorder with mixed features differ in peripheral biochemical parameters.
Observational study in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03949218 (Bipolar Disorder and Oxidative Stress Injury Mechanism - Clinical Big Data Analysis Based on Machine Learning), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Bipolar Disorder and Oxidative Stress Injury Mechanism - Clinical Big Data Analysis Based on Machine Learning
Who cites it
2 citing papers in PubMed.
- Identifying treatment response classes to transcranial direct current stimulation from daily ecological momentary assessment patterns in patients with depression.The international journal of neuropsychopharmacology · 2026Trial
- An Integrated Treatment Approach for Bipolar II Disorder: A Clinical Case Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLittle is known about the peripheral biochemicals between bipolar disorder at mixed episodes (BDM) and major depressive disorder with mixed features (MDM). This retrospective study was aimed to compare the peripheral biochemical parameters between patients with BDM and MDM.
methodsThis study included data from 269 BDM patients and 86 MDM patients. Biochemical markers covering immune-inflammatory, liver function, metabolic, and thyroid hormone indices were analyzed. Logistic regression models were employed to evaluate associations between biochemical markers and diagnosis. Network analysis and Principal Component Analysis (PCA) was also performed to investigate the relationships among these parameters.
resultsBDM patients had higher neutrophil percentage (NEUT%), white blood cell count (WBC), free triiodothyronine (FT3) and free thyroxine (FT4), while MDM patients exhibited higher levels of C-reactive protein (CRP), direct bilirubin (DBIL) and prealbumin (PA). NEUT%, WBC, FT3 and FT4 showed positive association with the diagnosis of BDM, while PA and DBIL displayed negative correlation with BDM. No significant differences in either network structure or global strength were found between BDM and MDM groups.
conclusionPeripheral biochemical markers, particularly those related to the immune-inflammatory factors and thyroid hormones, differ between BDM and MDM, which could contribute to better understanding of potential status mechanism under the disorders.
trial registrationInternational Clinical Trials Registry Platform: NCT03949218. Registered on 13/05/2019.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.